The Wiedemann-Steiner Syndrome Foundation, in partnership with the Orphan Disease Center University of Pennsylvania, is proud to announce three new 2-year research grants to support scientific advancement in Wiedemann-Steiner Syndrome (WSS).
WSS is a rare genetic disorder caused by mutations in the KMT2A (MLL) gene, impacting gene expression and leading to significant cognitive and behavioral challenges.
Grant Opportunities:
– Two $90,000 awards: Support the development of patient-derived cell models (e.g., iPSCs, neurons) to accelerate therapeutic discovery. These models will be made publicly available through a biobank.
– One $90,000 award: Support a Natural History Study to better understand the progression of WSS over time—critical for future treatment development.
Eligibility: All individuals holding a faculty-level appointment at an academic institution or a senior position at a non-profit institution or foundation are eligible to respond to this RFA. Letters of Interest due by Friday, August 8, 2025, by 8 PM ET.
More information: https://orphandiseasecenter.squarespace.com/grants/wiedemannsteinerloi